Kuroiwa Yuichi, Okamura Toshiya, Ishii Yuji, Umemura Takashi, Tasaki Masako, Kanki Keita, Mitsumori Kunitoshi, Hirose Masao, Nishikawa Akiyoshi
Division of Pathology, National Institute of Health Sciences, 1-18-1 Kamiyoga, Setagaya-Ku, Tokyo 158-8501, Japan.
Cancer Sci. 2008 Jan;99(1):7-13. doi: 10.1111/j.1349-7006.2007.00649.x. Epub 2007 Oct 22.
Combined treatment with sodium nitrite (NaNO2) and ascorbic acid (AsA) has already been shown to promote rat forestomach carcinogenesis, possibly due to nitric oxide generation under acidic conditions. We hypothesized that a similar effect might occur in the esophagus when the luminal pH is decreased by acid reflux. To clarify this possibility, reflux esophagitis model rats (F344 male) were coadministered 0.2% NaNO2 in the drinking water and 1% AsA in the diet. After 32 weeks of the combined treatment, a significant increase in the incidence of epithelial hyperplasias of the lower-middle and lowest parts of the esophagus were observed compared with the basal-diet group, along with exacerbation of dysplasia and extension of the lesions. Additionally, one squamous cell papilloma was found only in the combined-treatment group. Subsequently, we confirmed the enhancing effects of NaNO2 and AsA cotreatment in the rat N-bis(2-hydroxypropyl)nitrosamine-initiated esophageal tumorigenesis model. The incidence of hyperplasia was enhanced in all segments, along with the incidence and multiplicity of squamous cell papillomas in the lowest segment of the esophagus. Thus, the data demonstrate that combined treatment with NaNO2 and AsA exerts promoting effects on rat esophageal carcinogenesis under acid reflux conditions, as in the forestomach. These findings suggest that the risk of excessive intake of a combination of nitrite and antioxidants for esophageal carcinogenesis is appreciable, particularly in patients with reflux esophagitis.
亚硝酸钠(NaNO₂)与抗坏血酸(AsA)联合治疗已被证明会促进大鼠前胃癌变,这可能是由于在酸性条件下产生了一氧化氮。我们推测,当管腔pH值因胃酸反流而降低时,食管可能会出现类似的效应。为了阐明这种可能性,我们对反流性食管炎模型大鼠(F344雄性)进行了联合治疗,在饮用水中添加0.2%的NaNO₂,并在饮食中添加1%的AsA。联合治疗32周后,与基础饮食组相比,食管中下部和最低部位的上皮增生发生率显著增加,同时发育异常加剧,病变范围扩大。此外,仅在联合治疗组中发现了一例鳞状细胞乳头状瘤。随后,我们在大鼠N-双(2-羟丙基)亚硝胺引发的食管肿瘤发生模型中证实了NaNO₂和AsA联合治疗的增强作用。增生发生率在所有节段均有所增加,食管最低节段的鳞状细胞乳头状瘤的发生率和多发性也有所增加。因此,数据表明,与前胃一样,在胃酸反流条件下,NaNO₂和AsA联合治疗对大鼠食管癌发生具有促进作用。这些发现表明,过量摄入亚硝酸盐和抗氧化剂组合会增加食管癌发生风险,这一点值得重视,尤其是对于反流性食管炎患者。